Sol-Gel Technologies Ltd. revenue breakdown overview

Sol-Gel Technologies Ltd. revenue for the last year amounted to 1.55 M USD, the most of which — 1.55 M USD — came from its highest performing source at the moment, Topical Dermatological Drug, the year earlier bringing 3.88 M USD. The greatest contribution to the revenue figure was made by Israel — last year it brought Sol-Gel Technologies Ltd. 1.55 M USD, and the year before that — 3.88 M USD.